Poolbeg Pharma Ltd. (GB:POLB)
LSE:POLB
Want to see GB:POLB full AI Analyst Report?
Total Valuation
Poolbeg Pharma Ltd. has a market cap or net worth of £54.29M. The enterprise value is 33.54M .
Market Cap£54.29M
Enterprise Value33.54M
Share Statistics
Poolbeg Pharma Ltd. has 705,103,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding705,103,760
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Poolbeg Pharma Ltd.’s return on equity (ROE) is -0.66 and return on invested capital (ROIC) is -73.60%.
Return on Equity (ROE)-0.66
Return on Assets (ROA)-0.57
Return on Invested Capital (ROIC)-73.60%
Return on Capital Employed (ROCE)-0.75
Revenue Per Employee0.00
Profits Per Employee-379.67K
Employee Count15
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Poolbeg Pharma Ltd. is ―. Poolbeg Pharma Ltd.’s PEG ratio is 0.22.
PE Ratio―
PS Ratio0.00
PB Ratio2.80
Price to Fair Value2.80
Price to FCF0.00
Price to Operating Cash Flow-12.01
PEG Ratio0.22
Income Statement
In the last 12 months, Poolbeg Pharma Ltd. had revenue of 0.00 and earned -5.70M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-6.42M
Pretax Income-5.77M
Net Income-5.70M
EBITDA-6.42M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -4.51M and capital expenditures 2.16M, giving a free cash flow of -2.35M billion.
Operating Cash Flow-4.51M
Free Cash Flow-2.35M
Free Cash Flow per Share>-0.01
Dividends & Yields
Poolbeg Pharma Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change108.11%
50-Day Moving Average5.05
200-Day Moving Average4.29
Relative Strength Index (RSI)71.47
Average Volume (3m)1.12M
Important Dates
Poolbeg Pharma Ltd. upcoming earnings date is Sep 8, 2026, TBA (Not Confirmed).
Last Earnings DateApr 28, 2026
Next Earnings DateSep 8, 2026
Ex-Dividend Date―
Financial Position
Poolbeg Pharma Ltd. as a current ratio of 6.17, with Debt / Equity ratio of 0.00%
Current Ratio6.17
Quick Ratio6.17
Debt to Market Cap0.00
Net Debt to EBITDA1.20
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Poolbeg Pharma Ltd. has paid -79.00K in taxes.
Income Tax-79.00K
Effective Tax Rate0.01
Enterprise Valuation
Poolbeg Pharma Ltd. EV to EBITDA ratio is -2.55, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA-2.55
EV to Free Cash Flow0.00
EV to Operating Cash Flow-3.64
Balance Sheet
Poolbeg Pharma Ltd. has £7.71M in cash and marketable securities with £0.00 in debt, giving a net cash position of £7.71M billion.
Cash & Marketable Securities£7.71M
Total Debt£0.00
Net Cash£7.71M
Net Cash Per Share£0.01
Tangible Book Value Per Share£0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Poolbeg Pharma Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast19.83%